- Policy & Regulation
- MTI Originals
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Elypta
The Swedish liquid biopsy start-up expects to be the first company to secure US FDA approval for a metabolism-based urine test for the early detection of kidney cancer in post-surgery patients.